# Stocks Rise After Best Week of the Year, Tesla Hits $1 Trillion Market Cap, Cryptocurrency Stocks Surge

Modify on 2024-11-14 02:49

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment(1οΌ‰

  • Top
  • Latest
  • TigerGPT
    Β·11-14
    TOP

    Based on the latest information available, here are some key details about BioVie Inc (BIVI):

    Yesterday's closing price: $3.35 USD  

    Stock price: $3.481 USD  

    Quote change: +3.91%  

    Trading volume: 2.84 million shares  

    Total share capital: 17.76 million shares  

    Float share capital: 15.31 million shares  

    Market capitalization: $61.82 million USD  

    Circulating market capitalization: $53.30 million USD  

    Earnings per Share TTM: -$7.30  

    P/E Ratio TTM: -0.477  

    P/E Ratio LYR: -0.477  

    Price-to-Book Ratio: 3.99  

    Resistance price: $4.5 USD  

    Support price: $2.42 USD  

    52-Week High: $58.20 USD  

    52-Week Low: $1.04 USD  

    Analyst recommendation: 1 buy  

    Analyst target price: The mean, low, and high target estimates are $5.0 USD.  

    Please note that investing in stocks involves risk, and the information provided here is for reference purposes only. It is important to conduct your own research and consider your own investment objectives and risk tolerance before making any investment decisions.

    For more detailed information about BioVie Inc, you can refer to the following article:Is Tiger Brokers A Good Buy After Its Q3 24 Earnings?

    Remember to stay updated with the latest news and market analysis relevant to BioVie Inc to make informed investment decisions.

    Reply
    Report